RHUMBLINE ADVISERS - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 111 filers reported holding DICE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 11.16 and the average weighting 1.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,475,667
+159106.9%
53,286
-1.8%
0.00%
+50.0%
Q1 2023$1,555
-3.4%
54,265
+5.2%
0.00%0.0%
Q4 2022$1,610
-99.8%
51,590
+21.4%
0.00%
+100.0%
Q3 2022$862,000
+38.8%
42,491
+6.2%
0.00%0.0%
Q2 2022$621,000
+122.6%
40,022
+174.3%
0.00%
Q1 2022$279,000
+6.5%
14,590
+41.2%
0.00%
Q4 2021$262,00010,3320.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders